exam 2 review

Question 1

FDA approved for bipolar depression

Answer 1

seroquel (quetapine)
symbyax (olanzapine-fluoxetine)
Vraylar (cariprazine)
Latuda (lurasidone)

Question 2

Lower risk of EPS

Answer 2

Olanzapine
Quetiapine
clozapine

Question 3

high risk of QT prolongation

Answer 3

Geodon
seroquel
Fanapt (iloperidone)
Mellaril (thioridazine)

Question 4

treatment of dystonia

Answer 4

benztropine (Cogentin) IM

Benadryl IM

Question 5

treatment of akathisia

Answer 5

Propanolol

Lorazepam

Question 6

treatment of tardive dyskinesia

Answer 6

VMAT2 inhibitors

Question 7

plasma levels of lithium for depression

Answer 7

0.6-1.0

Question 8

plasma levels of lithium for mania

Answer 8

1.0-1.5

Question 9

plasma levels of lithium for maintenance

Answer 9

0.7-1.0

Question 10

how often to monitor lithium levels

Answer 10

every 1-2 weeks until stable
every 2-3 months for first 6 months
every 6-12 months when stable

Question 11

how often to monitor kidney function while on lithium

Answer 11

1-2 times per year

Question 12

how often to monitor TSH while on lithiumm

Answer 12

initial, at 6 months, then yearly

Question 13

FDA approved for acute mania

Answer 13

lithium, depakote

Question 14

FDA approved for maintenance bipolar 1

Answer 14

lamotrigine

lithium

Question 15

H1 receptor antagonism side effect

Answer 15

sedation and weight gain

Question 16

Give for parkinsonism

Answer 16

beztropine (cogentin)